BCRX
BioCryst Pharmaceuticals, Inc. · Healthcare
President and CEO Jon P Stonehouse sold $1.0M of BioCryst Pharmaceuticals, Inc.
Sold$1,038,000
$10.38Price
100,000Shares
−9%Stake
What BCRX did after the filing
- The stock from Thu, Feb 2 close, $10.74
- −24.6%
- S&P 500, same days
- −6.1%
Measured over 30 trading days, to the Mar 17 close.
Traded Wed, Feb 1. Filed Thu, Feb 2, 12:20 PM ET, during the session. Returns use the Feb 2 close and the Mar 17 close. Not investment advice.